Dr. Marchi is an accomplished researcher and has been involved in the discovery of novel therapeutic strategies in the laboratory that have now been translated into clinical trials for patients with T-cell lymphomas. Because of her expertise, she has been named co-director of the Program for T-Cell Lymphoma Research at UVA and the deputy director of the Global T-Cell Lymphoma Consortium (GTCLC). This consortium brings together top research scientists from around the world to advance the care of these rare forms of cancer.